Ardent Health Partners (NYSE:ARDT) Releases Earnings Results, Beats Estimates By $0.31 EPS

Ardent Health Partners (NYSE:ARDT) issued its quarterly earnings data on Wednesday. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31, Zacks reports. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion. Ardent Health Partners updated its FY 2025 guidance to 1.730-2.010 EPS.

Ardent Health Partners Stock Performance

NYSE:ARDT traded down $0.86 on Friday, reaching $14.31. 211,776 shares of the company’s stock traded hands, compared to its average volume of 382,772. The stock has a 50-day simple moving average of $15.23 and a 200-day simple moving average of $16.84. Ardent Health Partners has a 12 month low of $13.55 and a 12 month high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ARDT shares. Leerink Partners boosted their price target on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Morgan Stanley dropped their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $21.36.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.